Opioid receptor PET reveals the psychobiologic correlates of reward processing

Journal of Nuclear Medicine

Volumn 49, Issue 8, 2008, Pages 1257-1261

  Schreckenberger, Mathias ^a   Klega, André ^a   Gründer, Gerhard ^a,b   Buchholz, Hans Georg ^a   Scheurich, Armin ^a   Schirrmacher, Ralf ^a,c   Schirrmacher, Esther ^a,c   Müller, Christina ^a   Henriksen, Gjermund ^d   Bartenstein, Peter ^a,e  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c MCGILL UNIVERSITY   (Canada)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Addiction; Drug abuse; Opioid receptor; Personality; Positron emission tomography

Indexed keywords

FLUOROETHYLDIPRENORPHINE F 18; OPIATE RECEPTOR; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADDICTION; ADULT; ARTICLE; BEHAVIOR; BINDING AFFINITY; BRAIN MAPPING; CALCULATION; COGNITION; CORPUS STRIATUM; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTRANSMISSION; NORMAL HUMAN; NUCLEUS ACCUMBENS; OCCIPITAL CORTEX; PERSONALITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOBIOLOGY; PSYCHOLOGIC TEST; REWARD; SENSORY STIMULATION; SOCIAL ASPECT; STATISTICAL ANALYSIS; STEREOTACTIC PROCEDURE; TEMPERAMENT;

ADULT; BASAL GANGLIA; BRAIN; BRAIN MAPPING; CAUDATE NUCLEUS; DIPRENORPHINE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; NUCLEUS ACCUMBENS; PERSONALITY; RADIOPHARMACEUTICALS; RECEPTORS, OPIOID; REWARD;

EID: 48749100991     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.050849     Document Type: Article

References (27)

1. Costa PT Jr, McCrae RR. Ego development and trait models of personality. Psychol Inq. 1993;4:20-23.
2. Canli T. Functional brain mapping of extraversion and neuroticism: learning from individual differences in emotion processing. J Pers. 2004;72:1105-1132.
3. Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry. 1987;44:573-588.
4. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975-990.
5. Cloninger CR. Temperament and personality. Curr Opin Neurobiol. 1994;4:266-273.
6. Moresco FM, Dieci M, Vita A, et al. In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study. Neuroimage. 2002;17:1470-1478.
7. Pecina S, Berridge KC. Opioid site in nucleus accumbens shell mediates eating and hedonic 'liking' for food: map based on microinjection Fos plumes. Brain Res. 2000;863:71-86.
8. 11C]DPN in humans. J Nucl Med. 2000;41:1279-1286.
9. 18F]-repaglinide): a promising radioligand for quantification of pancreatic β-cell mass with positron emission tomography (PET). Nucl Med Biol. 2004;31:639-647.
10. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840.
11. Lochmann M, Buchholz HG, Siessmeier T, Schreckenberger M, Rösch F, Bartenstein P. Comparison of different quantification methods for calculating binding potential (BP) of the new unselective opiate-receptor ligand F-18 fluor-ethyl-diprenorphine. J Cereb Blood Flow Metab. 2003;23(suppl 1):669.
12. 11C]diprenorphine and positron emission tomography. J Cereb Blood Flow Metab. 1991;11:204-219.
13. Koepp MJ, Richardson MP, Brooks DJ, Duncan JS. Focal cortical release of endogenous opioids during reading-induced seizures. Lancet. 1998;352:952-955.
14. Friston KJ, Frith CD, Frackowiak RS, Turner R. Characterizing dynamic brain responses with fMRI: a multivariate approach. Neuroimage. 1995;2:166-172.
15. 2 receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab. 2001;21:1034-1057.
16. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science. 1997;275:1593-1599.
17. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP. Effect of naltrexone on alcohol "high" in alcoholics. Am J Psychiatry. 1995;152:613-615.
18. 2 receptors in the insular cortex and the personality trait of novelty seeking. Neuroimage. 2001;13:891-895.
19. Kalin NH, Shelton SE, Lynn DE. Opiate systems in mother and infant primates coordinate intimate contact during reunion. Psychoneuroendocrinology. 1995;20:735-742.
20. Zubieta JK, Smith YR, Bueller JA, et al. Regional m opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293:311-315.
21. Heinz A, Reimold M, Hermann D, et al. Correlation of stable elevations in striatal μ-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry. 2005;62:57-64.
22. Gonzales RA, Weiss F. Suppression of ethanol-reinforced behaviour by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci. 1998;18:10663-10671.
23. Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 1999;22:521-527.
24. Gianoulakis C. Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J Psychiatry Neurosci. 2001;26:304-318.
25. 11C]diprenorphine PET study. Pain. 2004;108:213-220.
26. 18F]diprenorphine kinetics in the human brain with compartmental and non-compartmental modeling approaches. Neuroimage. 2004;22:1523-1533.
27. 11C]diprenorphine studies [abstract]. J Cereb Blood Flow Metab. 2003;23(suppl 1):679.